CompletedPhase 3

Efficacy on Height in SGA Children Treated With Growth Hormone

Czechia151 participantsStarted 2002-11

Plain-language summary

This trial is conducted in Europe and Middle East. Growth hormone in SGA Children This trial compares a treated group of patients with an untreated group of patients.

Who can participate

Age range3 Years – 7 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Born small for gestational age with length and/or weight at -2 SDS or below at time of birth, according to country specific references. * Severe growth failure with no catch up and with height at -2.5 SDS or below, according to country specific references, for chronological age at time of inclusion Exclusion Criteria: * Growth Hormone Deficiency (GHD) * Treatment with any medical product which may interfere with GH effects * Growth retardation associated with infections, severe chronic diseases including chromosomal anomaly or nutritional disorders

What they're measuring

Evaluate effect on Height in SGA Children Treated with Growth Hormone

Timeframe: After 2 years of treatment

Trial details

NCT IDNCT00184756

SponsorNovo Nordisk A/S

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2006-07

View on ClinicalTrials.gov More Foetal Growth Problem trials